Compliant Multiple Attribute Monitoring (MAM) of therapeutic proteins for manufacturing control

Compliant CQA monitoring of therapeutic proteins for manufacturing control

Modern biopharmaceutical drugs, such as monoclonal antibodies (mAbs) and antibody drug conjugates (ADCs), are tremendously complex molecules manufactured inside living cells. Characterizing and monitoring these compounds in chemistry, manufacturing and controls (CMC), and quality control environments can present a significant challenge, but the use of high resolution accurate mass (HRAM) mass spectrometry offers a powerful way of overcoming these challenges.

The additional dimension of separation combined with the sensitivity and specificity of Orbitrap MS yields deeper product knowledge than a combined battery of conventional characterization tests, eliminating a large number of traditional lot release testing. 

By directly measuring critical quality attributes at the individual residue level, understanding how changes in process or production affect a drug product becomes part of a "quality by design" approach. Together, the results provided by HRAM MS enable safer and more potent drugs to be manufactured, delivering a truly powerful research-to-routine workflow.

Speak to a specialist

Recommended GMP-compliant MS in QC workflow components

Mass spectrometry in QC bottom-up workflow

Mass Spectrometry in Biopharma QC workflow

The adoption of mass spectrometry (MS) in quality control workflows is discussed in this Chemical & Engineering News article. MS experts talk about using mass spectrometry in pilot plants to replace some of the more traditional quality control assays. MS allows the detection of slight changes in biotherapeutics due to its increased sensitivity and specificity: …the only instrument able to consistently detect these new peaks is the Orbitrap…”

How can HRAM MS reduce the number of individual CQA assessments?

Adapted from Rogers, R. et al. MS in QC: A Single Multi-attribute Method for Quality Control and Release Testing of Biologics. Presented at CASSS MS 2013, Boston, September 24 2013.

  Yes = Yes No = No Sometimes = Sometimes

To adequately cover the numerous different critical quality attributes required during QC analysis, several different analytical strategies are typically performed. Many of these analyses are time intensive and only serve to provide one piece of information.

Multi-attribute method (MAM) analysis (via peptide mapping) serves to provide significant amounts of information for biotherapeutic drugs, both reducing the number of analyses and different experiments required to be performed whilst increasing the product quality profile.

Powerful and compliant informatics for MAM of biotherapeutic drugs

Take protein characterization data from discovery with the identification of critical quality attributes using Thermo Scientific BioPharma Finder software seamlessly into routine GMP compliant monitoring using the powerful MS processing features in Thermo Scientific Chromeleon 7.2 Chromatography Data System (CDS) software. Confidently and robustly monitor multiple critical quality attributes in a single sequence in high resolution to ensure that your biotherapeutic drugs are adequately controlled.

Chromeleon software unifies workflows for chromatography and MS analysis, providing full integration of LCMS data acquisition, auditing, processing, and reporting—you even manage third party LC systems. Quickly and easily process and report UV and MS data in one application with the ability to run your analyses in an enterprise environment, while complying with GxP regulatory requirements such as 21 CFR Part 11.

Identifying a deamidated Trastuzumab peptide in Chromeleon CDS software.
Click to enlarge
Identification of an isoaspartic acid containing peptide from the NIST mAb standard using Chromeleon CDS software.

Identification of non-targeted peaks which could require additional elucidation—ensuring that nothing is missed.

Integral components of a robust and sensitive MAM workflow

Obtain confident peptide separations, every time

The Thermo Scientific Vanquish Flex Binary UHPLC and the Vanquish Horizon UHPLC platforms offers ultimate biocompatible state-of-the-art binary or quaternary solvent blending, along with new benchmarks in accuracy, precision, and sensitivity in peptide chromatography. With rock-steady retention times, you can be confident in the identity of every peptide in discovery, development, and QC environments.


Featured videos
Innovative Analytical Strategies for Monitoring Critical Process Parameters and Critical Quality Attributes (CQA)

Learn more about MS in QC and how innovation and monitoring strategies can reduce the number of tests and enhance the methodology of validating impurity.

QbD Using HRAM MS for Biotherapeutic Drug Analysis

Extending the capabilities of a MS-based multi-attribute characterization method to promote quality by design In biotherapeutic drugs.